Anavex Life Sciences (AVXL) Offers Statistically Significant Preclinical ANAVEX 3-71 Data in Alzheimer’s Disease
Tweet Send to a Friend
Anavex Life Sciences Corp. (Nasdaq: AVXL) announced positive preclinical data on sigma-1 agonist ANAVEX 3-71 (formerly AF710B). The results ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
